NNHF launches 2021-25 strategy to continue ‘Impacting care. Together’

Strategic goals to strengthen network, foster advocacy and expand funding will increase support for the haemophilia and allied bleeding disorders community.

The Novo Nordisk Haemophilia Foundation is launching an updated strategic direction for the next five years under the banner of ‘Impacting care. Together’. The 2021-25 strategy is set by the NNHF Council to support the ambitions of the organisation and impact the wide-ranging needs of its project partners and other stakeholders.

“Our strategy will drive the NNHF to achieve ambitious objectives as an organisation dedicated to improving care and treatment of haemophilia all over the world,” says Ludovic Helfgott, Council President. “We want to scale up and expand our offering to benefit more people with bleeding disorders in more and better ways, while keeping the grassroots approach that has been the hallmark of our programmes over the past 15 years.”

Three strategic goals to strengthen impact

The NNHF has set three strategic objectives to guide its efforts: strengthen network, foster advocacy and expand funding. Each is designed to contribute to the overarching goal of increasing the organisation’s impact on care to benefit more people with bleeding disorders globally.

These objectives are closely interlinked, explains Denise Braendgaard, General Manager: “In strengthening and expanding our network, we will open up to new donors and build more opportunities for our partners. Leveraging synergies among different organisations will also give our partners a stronger voice when advocating for better access to care for people with haemophilia.”

The strategic plan has been developed with input from the NNHF programme partners to reflect their evolving needs for development and expertise. While the focus of the organisation remains on the care and treatment of haemophilia, there is strong evidence to support the benefits of joining forces to broaden reach and increase impact. Examples can be seen through several recent initiatives: in Nepal, where the project team has worked together with the Disabled People’s Organisation to support their advocacy efforts; in Kenya and Tanzania, a joint approach between haemophilia and sickle cell disease is working to benefit more people with bleeding disorders. 

“The NNHF team have successfully built trusted, high-quality relationships with external experts and partners in 78 countries since we began working with the haemophilia community in 2005. As we look ahead to the next five years, we see great potential in encouraging our partners to collaborate with other organisations and related disease areas. We strongly believe that such initiatives will be key to intensifying and accelerating our impact together in the future,” says Denise Braendgaard.

In line with the organisation’s purpose and core values, the NNHF will maintain a needs-driven approach to projects and measure achievements not only through key performance indicators but based on the depth of its impact on the lives of people with haemophilia and allied bleeding disorders.